이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sintx Technologies 관리

관리 기준 확인 3/4

Sintx Technologies' CEO는 B. Bal, Oct2014 에 임명되었습니다 의 임기는 9.67 년입니다. 총 연간 보상은 $ 536.95K, 76.9% 로 구성됩니다. 76.9% 급여 및 23.1% 보너스(회사 주식 및 옵션 포함). 는 $ 5.65 가치에 해당하는 회사 주식의 0% 직접 소유합니다. 5.65. 경영진과 이사회의 평균 재임 기간은 각각 9.1 년과 10 년입니다.

주요 정보

B. Bal

최고 경영자

US$537.0k

총 보상

CEO 급여 비율	76.9%
CEO 임기	9.7yrs
CEO 소유권	0.0002%
경영진 평균 재임 기간	9.1yrs
이사회 평균 재임 기간	10yrs

최근 관리 업데이트

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Nov 29

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Dec 09

Recent updates

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Nov 29

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Dec 09

SINTX Technologies jumps 25%, gets order for aerospace components

Oct 11

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

Sep 27

SINTX Technologies acquires Technology Assessment and Transfer

Jul 06

SINTX Technologies joins Russell Microcap Index

Jun 09

CEO 보상 분석

B. Bal 의 보수는 Sintx Technologies 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	-US$9m
Dec 31 2023	US$537k	US$413k	-US$8m
Sep 30 2023	n/a	n/a	-US$14m
Jun 30 2023	n/a	n/a	-US$14m
Mar 31 2023	n/a	n/a	-US$14m
Dec 31 2022	US$512k	US$400k	-US$16m
Sep 30 2022	n/a	n/a	-US$10m
Jun 30 2022	n/a	n/a	-US$10m
Mar 31 2022	n/a	n/a	-US$10m
Dec 31 2021	US$483k	US$400k	-US$9m
Sep 30 2021	n/a	n/a	-US$9m
Jun 30 2021	n/a	n/a	-US$9m
Mar 31 2021	n/a	n/a	-US$11m
Dec 31 2020	US$487k	US$415k	-US$17m
Sep 30 2020	n/a	n/a	-US$16m
Jun 30 2020	n/a	n/a	-US$15m
Mar 31 2020	n/a	n/a	-US$14m
Dec 31 2019	US$401k	US$400k	-US$7m
Sep 30 2019	n/a	n/a	-US$8m
Jun 30 2019	n/a	n/a	-US$15m
Mar 31 2019	n/a	n/a	-US$22m
Dec 31 2018	US$412k	US$400k	-US$24m
Sep 30 2018	n/a	n/a	-US$24m
Jun 30 2018	n/a	n/a	-US$17m
Mar 31 2018	n/a	n/a	-US$9m
Dec 31 2017	US$482k	US$400k	-US$6m

보상 대 시장: B. 의 총 보상 ($USD 536.95K )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 683.56K ).

보상과 수익: 회사가 수익성이 없는 동안 B. 의 보상이 증가했습니다.

CEO

B. Bal (62 yo)

9.7yrs

테뉴어

US$536,951

보상

Dr. B. Sonny Bal, M.D. J.D. MBA, PhD, has been the Chief Executive Officer and President of Sintx Technologies, Inc. (formerly known as Amedica Corporation) since October 2014 and its Chairman since August...

리더십 팀

이름	위치	테뉴어	보상	소유권
B. Bal	CEO, President	9.7yrs	US$536.95k	0.00016% $ 5.7
David O'Brien	Executive VP & COO	9.1yrs	US$483.60k	0.00049% $ 17.3
Michael Marcroft	Vice President of Sales & Marketing	1.4yrs	데이터 없음	데이터 없음
Gina Moss	Director of Operations	no data	데이터 없음	데이터 없음

9.1yrs

평균 재임 기간

경험이 풍부한 관리: SINT 의 관리팀은 노련하고 경험 (평균 재직 기간 9.1 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
B. Bal	CEO, President	12.3yrs	US$536.95k	0.00016% $ 5.7
David Truetzel	Independent Director	13.8yrs	US$124.21k	0% $ 0
Erik Stookey	Independent Director	9.7yrs	US$43.43k	0% $ 0
Jeffrey White	Independent Director	10.4yrs	US$43.43k	데이터 없음
Mark Froimson	Independent Director	5.3yrs	US$43.18k	0% $ 0
Giuseppe Pezzotti	Member of Scientific Advisory Board	8.8yrs	데이터 없음	데이터 없음

10.0yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: SINT 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 10 년).

Sintx Technologies 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Sintx Technologies, Inc., Annual General Meeting, Dec 05, 2023

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Insufficient new directors

Sintx Technologies, Inc., Annual General Meeting, Dec 15, 2022

Insufficient new directors

Recent updates

Sintx Technologies Regains Compliance with Nasdaq Bid Price Requirement

Consensus revenue estimates decrease by 12%

Sintx Technologies Declares 1-for-200 Reverse Stock Split Effective May 28, 2024 to Bring it into Compliance with the Minimum Bid Price Requirements for Maintaining the Listing on the Nasdaq Capital Market

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies Receives New Notification Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

Sintx Technologies, Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings: EPS misses analyst expectations

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $1.030519 million.

Consensus revenue estimates increase by 17%

Sintx Technologies, Inc. Provides Estimated Revenue for the Fourth Quarter and Full Year Ended December 31, 2023

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sintx Technologies, Inc., Annual General Meeting, Dec 05, 2023

SINTX Technologies Receives a Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

Sintx Technologies, Inc. Receives Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

New major risk - Revenue and earnings growth

No longer forecast to breakeven

Second quarter 2023 earnings released: US$0.61 loss per share (vs US$10.16 loss in 2Q 2022)

Consensus EPS estimates fall by 16%

Consensus EPS estimates upgraded to US$2.53 loss

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 78% to US$23.00

Price target increased by 80% to US$200

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 70% to US$200

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $12.04 million.

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $12.04 million.

Sintx Technologies, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2022

Consensus forecasts updated

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Sintx Technologies Receives Notice from the Listing Qualifications Staff of Nasdaq

Consensus revenue estimates increase by 32%

Insufficient new directors

Sintx Technologies, Inc., Annual General Meeting, Dec 15, 2022

Price target increased to US$2.50

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $4.7 million.

SINTX Technologies jumps 25%, gets order for aerospace components

Sintx Technologies, Inc. Announces New Antibacterial Biomedical Patents and Expansion of Intellectual Property Portfolio

National Institutes of Health Announces Grant to Sintx Technologies for Development of 3D Printed Antimicrobial Trauma Device

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

Oxford Performance Materials and SINTX Technologies Collaboration Yields Major Breakthrough in Orthopedic & Dental Coatings

No longer forecast to breakeven

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies, Inc. (NasdaqCM:SINT) acquired Technology Assessment And Transfer, Inc. for 0.76 million.

SINTX Technologies acquires Technology Assessment and Transfer

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to US$2.13

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Insufficient new directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

No longer forecast to breakeven

Insufficient new directors

SINTX Technologies, Inc. Announces New Results on the Development of Manufacturing Technologies to Produce Fabrics Impregnated with SINTX Silicon Nitride, and the Antipathogenic Testing of These Fabrics

SINTX Technologies Receives A Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

No longer forecast to breakeven

Price target decreased to US$3.00

Third quarter 2021 earnings released: US$0.095 loss per share (vs US$0.11 loss in 3Q 2020)

Consensus forecasts updated

Consensus revenue estimates fall to US$1.38m

Price target decreased to US$4.13

Consensus forecasts updated

Sintx Technologies, Inc. Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY

SINTX Technologies joins Russell Microcap Index

Consensus revenue estimates fall to US$1.10m

First quarter 2021 earnings released: US$0.11 loss per share (vs US$1.35 loss in 1Q 2020)

SINTX Technologies Announces New Product Brand, FleX SN, For Antipathogenic and Biomedical Applications

SINTX Technologies Files Multiple New U.S. and International Patent Applications